New jobs come to Syracuse with Ohio start-up company

Haleydine LLC moves to Syracuse from a suburb of Ohio to test air improvement system

By Kevin Barry (NCC News)
Oct. 28, 2010, 8 p.m.

SYRACUSE, N.Y. – The Syracuse job market could have more than 100 new openings within the next three to five years. The new jobs depend on the success of a revolutionary technology to sterilize the air in hospitals created by Haleydine LLC, a start-up company from Ohio that recently moved to Sryacuse.

Haleydine came to the Salt City because of its “global leading expertise” in two main areas of air quality, according to Kevin Schwab, the Vice President of CenterState CEO, a Syracuse-based economic development organization.

Those two areas are:
· In-door air quality devices
· Energy efficiency those devices

The new product uses new method of cleaning the air in hospitals, which can carry bacteria that cause infections to already weak patients.

The Old Method

The current way to clean hospital air involves moving air to keep patients from being exposed to its airborne germs. These systems have been gradually improving but are not always effective and use a lot of energy. They are also very expensive for companies to produce and for hospitals to buy.

“There is a significant issue in hospitals around the U.S. and around the world,” says Schwab. “That’s the growing problem of hospital acquired infections.”

Hospitals across the country spent billions of dollars on additional costs because of infection acquired while in the hospitals’ care, according to Schwab.

The Solution

Instead of just moving the air, Haleydine’s new system uses Ultraviolet Light to kill the airborne germs. As a result, it doesn’t have to move the air as much and is more efficient, making the hospital environment safer and not compromising the environment outside the hospital.

“They (Haleydine) are looking to create product that will cost less than the competition…use less energy and promises to be more effective than many alternatives that exist on the market right now,” says Schwab.

The system is being tested at St. Joseph’s hospital and data collected from its trial run will be presented to the government for approval to be sold on the market. Schwab says Haleydine’s new technology could be a “game-changer” if it works as intended.